Mark T Griffith

Title: Mark T Griffith: Innovator in GLP-1 Receptor Research

Introduction

Mark T Griffith is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that interact with the glucagon-like peptide 1 (GLP-1) receptor. With a total of 3 patents, his work has implications for therapeutic advancements in metabolic disorders.

Latest Patents

One of his latest patents focuses on GLP-1 receptor stabilizers and modulators. This invention provides compounds that bind to the GLP-1 receptor, including modulators and compounds that induce a stabilizing effect on the receptor. These compounds are essential for structural analysis of the GLP-1 receptor. The patent also outlines methods of synthesis, therapeutic and prophylactic use, and techniques for stabilizing the GLP-1 receptor in vitro for crystallization purposes. Another significant patent involves the structure of the human adenosine receptor protein bound to an antagonist. This invention discloses methods for utilizing binding sites and features of this G-protein coupled receptor to develop new therapeutics.

Career Highlights

Throughout his career, Mark T Griffith has worked with prominent organizations such as Receptos, Inc. and The Scripps Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Mark has collaborated with notable colleagues, including Marcus F Boehm and Esther Martinborough. These partnerships have further enriched his research and innovation efforts.

Conclusion

Mark T Griffith's contributions to GLP-1 receptor research exemplify his dedication to advancing therapeutic options in biochemistry. His innovative patents and collaborations highlight his role as a key figure in the scientific community.